Halozyme Therapeutics shares owned by Wafra Investment Advisory Group
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Wafra Investment Advisory Group
from 13F filings
Historical chart of Wafra Investment Advisory Group investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Wafra Investment Advisory Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Wafra Investment Advisory Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $2.2M | 54k | 40.68 |
| 2023-12-31 | $2.0M | 54k | 36.96 |
| 2023-09-30 | $1.1M | 30k | 38.20 |
More positions owned by Wafra Investment Advisory Group
View all positions for Wafra Investment Advisory Group